Tag: IHL

Impression Healthcare FDA cannabinoid drug candidate IHL-42X Camargo Pharmaceuticals ASX IHL

Impression Healthcare sets out FDA approval strategy for cannabinoid drug candidate IHL-42X

Medical cannabis company Impression Healthcare (ASX: IHL) has revealed it has received an independent strategic assessment report on the FDA approval pathway for cannabinoid IHL-42X...
Impression Healthcare CBD inhalers Australia Special Access Scheme lung inflammation COVID-19 coronavirus Asthma COPD Ventilin

Impression Healthcare acquires CBD inhalers for distribution under Australia’s Special Access Scheme

Medical cannabis company Impression Healthcare (ASX: IHL) came out of a trading halt late this morning to unveil an initial order for cannabidiol (CBD) pressurised metered-dose...
Impression Healthcare Liam Picken AFL ASX IHL traumatic brain injury TBI medical advisory board

Impression drafts former AFL star Liam Picken to its advisory board

Australian medical cannabis company Impression Healthcare (ASX: IHL) has taken yet another assertive step towards completing its clinical research program into concussion and traumatic brain...
Impression Healthcare ASX IHL traumatic brain injury medicinal cannabis

Impression Healthcare to launch medical cannabis trials for treatment of traumatic brain injury

Australian medical cannabis company Impression Healthcare (ASX: IHL) has finalised the design of a clinical program to assess novel cannabinoid formula IHL-216A on neurocognitive...
Impression Healthcare Incannex cannabinoid oil sales ASX IHL Cannvalate

Impression Healthcare expands cannabinoid oil sales program

Medical cannabis company Impression Healthcare (ASX: IHL) has expanded its cannabinoid oil sales program that runs side by side with its extensive base of clinical...
Impression Healthcare ASX IHL obstructive sleep apnoea clinical trial

Impression Healthcare prepares for obstructive sleep apnoea clinical trial

Medical cannabis company Impression Healthcare (ASX: IHL) is on course to begin a clinical trial using its IHL-42X drug candidate for the treatment of obstructive...
Impression Healthcare ASX IHL files patent non-intrusive treatment obstructive sleep apnoea pill

Impression Healthcare files patent for non-intrusive treatment of obstructive sleep apnoea

Medical cannabis company Impression Healthcare (ASX: IHL) is continuing on its path to developing an effective solution for obstructive sleep apnoea (OSA) having filed a...
Impression Healthcare ASX IHL John Michailidis Incannex cannabinoid pharmaceutical

Impression Healthcare recruits Big Pharma executive to complete cannabinoid drug discovery goal

Medical cannabis company Impression Healthcare (ASX: IHL) has continued its top-tier recruitment drive with the addition of yet another pharmaceutical industry expert into its...
Impression Healthcare ASX IHL cannabidiol head trauma

Impression Healthcare files patent application for medicinal CBD drug to alleviate concussion injuries

Impression Healthcare (ASX: IHL) has opted to file a patent application for a neuroprotective agent that could potentially aid people that suffer concussions – a...
Impression Healthcare ASX IHL medical advisory board wholesale order Incannex CBD oils

Duo of renowned specialists join Impression Healthcare, Incannex CBD oils on route

Following a busy few months on the recruitment and brand licencing fronts, Impression Healthcare (ASX: IHL) has appointed an additional duo of leading medical...
Impression Healthcare ASX IHL medical advisory board Rondhir Jithoo Simon Hinckfuss

Impression Healthcare appoints two globally renowned medical experts for cannabis medicines projects

Impression Healthcare (ASX: IHL) has bolstered its Medical Advisory Board by appointing two leading medical experts possessing extensive expertise within two key market niches currently being...

Impression Healthcare commences obstructive sleep apnoea clinical trial

Following last week’s deal that saw Impression Healthcare (ASX: IHL) secure the cannabinoid materials it needs to conduct a series of clinical trials, the...
Impression Healthcare ASX IHL Incannex Pharmaceuticals medicinal cannabis oil supply cannabinoid

Impression Healthcare secures long term oil supply agreement, unveils new cannabis discovery brand Incannex

Impression Healthcare (ASX: IHL) has moved to extend its medicinal cannabis market coverage after unveiling the all-new cannabinoid drug discovery brand Incannex Pharmaceuticals. As a...
ONE Championship Impression Healthcare ASX IHL mouthguard concussion research CBD

Impression Healthcare becomes official supplier and research partner to ONE Championship

Barely a week after Aurora announced a deal with the Ultimate Fighting Championship (UFC), Australia’s very own Impression Healthcare (ASX: IHL) has made a...
Dr Sud Agarwal Impression Healthcare ASX IHL Cannvalate cannabis

Impression Healthcare appoints leading medicinal cannabis pioneer Dr Sud Agarwal to its board

Impression Healthcare (ASX: IHL) has tweaked its internal structure by appointing Dr Sud Agarwal, a leading figure in the medicinal cannabis industry as its...
Impression Healthcare ASX IHL FiTGuard concussion monitoring system licence new countries

Impression Healthcare extends exclusive deal with FiTGuard for concussion monitoring

Impression Healthcare (ASX: IHL) has extended the global coverage of its Fitguard by Gameday concussion monitoring system by extending its exclusive licencing agreement with...
Impression Healthcare ASX IHL Dronabinol product supply agreement sleep apnoea trials sales

Impression Healthcare hones in on sleep apnoea trial with proprietary Dronabinol formulation

Impression Healthcare (ASX: IHL) is on the brink of conducting a sleep apnoea trial with its own variant of the cannabinoid medicine Dronabinol after...
Impression Healthcare ASX IHL Boxing Australia brain injury mouthguard CBD cannabidiol

Impression Healthcare becomes Boxing Australia’s official supplier and concussion research partner

Impression Healthcare (ASX: IHL) has unveiled a brand-new exclusive research and supply agreement that will see the healthcare company become the official traumatic brain...
Impression Healthcare ASX IHL AXIM gingivitis periodontitis gum disease cannabidiol CBD cannabis mouthwash toothpaste

Impression Healthcare registers clinical trial for CBD-based mouthwash and toothpaste

Impression Healthcare’s (ASX: IHL) “world first” clinical trial using its cannabidiol (CBD)-based mouthwash and toothpaste to treat gingivitis and periodontitis (gum disease) has now...
Impression Healthcare ASX IHL FiTGuard smart mouthguard concussion monitoring

Impression Healthcare to supply concussion monitoring FitGuard mouthguard system

Impression Healthcare (ASX: IHL) has inked an exclusive agreement to supply the concussion monitoring FitGuard mouthguard system. Under the agreement with Force Impact Technologies, Impression...
Impression Healthcare ASX IHL AXIM cannabis CBD periodontitis toothpaste mouthwash clinical trial

Impression Healthcare signs first binding agreement with AXIM Biotechnologies, clinical trial imminent

Impression Healthcare (ASX: IHL) is set to deliver a toothpaste and mouthwash product that adds yet another option for consumers searching for cannabidiol-based products. Earlier...

RECENT POSTS

STOCK SUMMARY

FOLLOW US

HOT TOPICS

TRENDING POSTS